Elevance Health (ELV) Stock Forecast, Price Target & Predictions
ELV Stock Forecast
Elevance Health (ELV) stock forecast, based on 38 Wall Street analysts, predicts a 12-month average price target of $472.21, with a high of $523.00 and a low of $395.00. This represents a 8.82% increase from the last price of $433.93.
ELV Stock Rating
Elevance Health stock's rating consensus is Buy, based on 38 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 27 Buy (71.05%), 11 Hold (28.95%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).
Buy
ELV Price Target Upside V Benchmarks
| Type | Name | Upside |
|---|---|---|
| Stock | Elevance Health | 8.82% |
| Sector | Healthcare Stocks | 15.45% |
| Industry | Healthcare Plans Stocks | 16.45% |
Price Target Trends
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 11 | 13 | 58 |
| Avg Price Target | $482.45 | $479.69 | $431.74 |
| Last Closing Price | $433.93 | $433.93 | $433.93 |
| Upside/Downside | 11.18% | 10.55% | -0.50% |
Ratings Trends
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell | Total |
|---|---|---|---|---|---|---|
| Nov, 26 | 3 | 12 | 7 | - | - | 22 |
| Oct, 26 | 2 | 12 | 8 | - | - | 22 |
| Sep, 26 | 3 | 12 | 7 | - | - | 22 |
| Aug, 26 | 3 | 12 | 7 | - | - | 22 |
| Jul, 26 | 2 | 12 | 8 | - | - | 22 |
Analyst Price Target Forecasts
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Nov 18, 2026 | David Toung | Argus Research | $510.00 | $421.50 | 21.00% | 17.53% |
| Oct 23, 2026 | Piper Sandler | $520.00 | $442.85 | 17.42% | 19.83% | |
| Oct 23, 2026 | Ann Hynes | Mizuho Securities | $490.00 | $445.28 | 10.04% | 12.92% |
| Oct 23, 2026 | Goldman Sachs | $451.00 | $445.28 | 1.28% | 3.93% | |
| Oct 22, 2026 | UBS | $523.00 | $439.10 | 19.11% | 20.53% | |
| Oct 22, 2026 | RBC Capital | $455.00 | $441.21 | 3.13% | 4.86% | |
| Oct 22, 2026 | Jason Cassorla | Guggenheim | $485.00 | $434.13 | 11.72% | 11.77% |
| Oct 22, 2026 | Robert W. Baird | $406.00 | $434.13 | -6.48% | -6.44% | |
| Oct 22, 2026 | Barclays | $472.00 | $434.13 | 8.72% | 8.77% | |
| Oct 12, 2026 | Jason Cassorla | Guggenheim | $460.00 | $412.70 | 11.46% | 6.01% |
Analyst Rating Forecasts
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 27, 2026 | Wells Fargo | Overweight | Overweight | hold |
| Oct 23, 2026 | Bernstein | Outperform | Outperform | hold |
| Oct 23, 2026 | Cowen & Co. | Buy | Buy | hold |
| Oct 23, 2026 | Goldman Sachs | Neutral | Neutral | hold |
| Oct 22, 2026 | RBC Capital | Sector Perform | Sector Perform | hold |
| Oct 22, 2026 | Bank of America Securities | Buy | Buy | hold |
| Oct 12, 2026 | Guggenheim | Buy | Buy | hold |
| Oct 09, 2026 | Cantor Fitzgerald | Overweight | Overweight | hold |
| Oct 07, 2026 | Barclays | Overweight | Overweight | hold |
| Jul 16, 2026 | Goldman Sachs | Neutral | Neutral | hold |
Financial Forecast
EPS Forecast
Annual
| Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | Dec 28 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|
| Reported | $25.25 | $24.56 | $25.38 | $25.81 | $25.18 | - | - | - | - |
| Avg Forecast | $25.94 | $29.02 | $33.07 | $33.21 | $34.49 | $39.12 | $45.09 | $53.01 | $60.81 |
| High Forecast | $26.78 | $29.93 | $33.17 | $33.39 | $35.31 | $43.70 | $46.79 | $55.16 | $63.27 |
| Low Forecast | $24.92 | $27.99 | $33.01 | $32.43 | $31.08 | $34.75 | $42.00 | $50.33 | $57.73 |
| Surprise % | -2.66% | -15.37% | -23.25% | -22.28% | -26.99% | - | - | - | - |
Revenue Forecast
Annual
| Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | Dec 28 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|
| Reported | $138.64B | $156.59B | $171.34B | $176.81B | $199.13B | - | - | - | - |
| Avg Forecast | $137.85B | $156.30B | $170.38B | $175.83B | $191.75B | $205.47B | $221.23B | $241.40B | $279.48B |
| High Forecast | $141.29B | $160.07B | $171.02B | $177.24B | $196.06B | $217.15B | $222.36B | $248.91B | $288.17B |
| Low Forecast | $133.66B | $152.01B | $169.32B | $174.23B | $183.87B | $194.40B | $220.09B | $232.01B | $268.60B |
| Surprise % | 0.57% | 0.19% | 0.56% | 0.56% | 3.85% | - | - | - | - |
Net Income Forecast
Annual
| Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | Dec 28 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|
| Reported | $6.10B | $5.89B | $5.99B | $5.98B | $5.66B | - | - | - | - |
| Avg Forecast | $5.67B | $6.08B | $5.99B | $7.67B | $7.74B | $9.14B | $10.35B | $12.36B | $14.17B |
| High Forecast | $6.81B | $7.30B | $7.18B | $7.78B | $8.23B | $10.19B | $10.91B | $12.86B | $14.75B |
| Low Forecast | $4.54B | $4.87B | $4.79B | $7.56B | $7.24B | $8.10B | $9.79B | $11.73B | $13.46B |
| Surprise % | 7.56% | -3.08% | - | -22.05% | -26.82% | - | - | - | - |